TP53 and cancer: The Asia Cancer Research Group (ACRG) proposed four molecular subtypes for GC based on microsatellite instability, epithelial–mesenchymal transition, and TP53 mutation: MSI, MSS/EMT, MSS/TP53+, and MSS/TP53- (Cristescu et al., 2015).